Skip to Content, Navigation, or Footer.
Indiana Daily Student
Friday, Oct. 18
Subscribe Donate
E-paper
The Indiana Daily Student

Eli Lilly announced Tuesday it would be pausing its COVID-19 vaccine trial, ACTIV-3, until further notice. Tribune News Service

EliLilly

Eli Lilly announced Tuesday it would be pausing its COVID-19 vaccine trial, ACTIV-3, until further notice.

Trending